查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
合同營銷機構全球市場規模研究與預測，按服務（個人促銷、非個人促銷）、最終用途（製藥公司、生物製藥公司）、區域分析，2022-2029 年
市場調查報告書
商品編碼
1262714

合同營銷機構全球市場規模研究與預測，按服務（個人促銷、非個人促銷）、最終用途（製藥公司、生物製藥公司）、區域分析，2022-2029 年

Global Pharmaceutical Contract Sales Organizations Market Size study & Forecast, by Service (Personal Promotion, Non-personal Promotion), by End-use (Pharmaceutical Companies, Biopharmaceutical Companies) and Regional Analysis, 2022-2029
出版日期: | 出版商: Bizwit Research & Consulting LLP | 英文 | 商品交期: 2-3個工作天內

價格

2021 年全球合同銷售代理市場價值約為 79 億美元，預計在 2022-2029 年預測期內將以超過 8.4% 的健康增長率增長。

製藥行業已受到審查，以擴大疫苗接種和其他有效治療替代品的生產能力。 合同銷售組織 (CSO) 領域的市場參與者正在使用這些進步來滿足消費者和醫療機構的需求。 合同藥品銷售 (CSO) 領域市場參與者的另一個主要收入驅動因素是增加對免疫系統潛力的了解。 對降低自銷成本的需求不斷增加、藥物研發活動增加以及新藥上市數量的增加是行業擴張的一些關鍵驅動因素。 此外，在 2022-2029 年的預測期內，政府的積極舉措和不斷增加的老年人口為市場創造了有利可圖的增長機會。

生產生物製藥的公司目前正專注於加強他們的研究能力。 根據 Pharma R&D 年度回顧，到 2022 年，近 45% 的在研藥物將是生物製藥。 由於對研究的高度興趣，生物製藥公司有望將其商業活動外包給 CSO，並專注於他們的研究能力。 然而，醫藥合同銷售機構的高成本將阻礙整個 2022-2029 年預測期內的市場增長。

全球合同營銷代理市場研究考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 2022年，北美市場份額最大，約佔全球行業收入的34.45%。 該地區增長的主要驅動力之一是大量 CSO 的存在，包括 IQVIA, Inc.、EPS Corp. 和 Axxelus。 該地區對藥品銷售新技術的接受以及該地區大量新藥的推出進一步推動了對製藥 CSO 的需求。 預計亞太地區將在預測期內以最快的速度增長。 由於該地區不斷開發新療法的製藥和生物製藥公司數量眾多，因此對 CSO 工作的需求量很大。 與其他新興市場相比，該地區以較低的成本提供 CSO 服務，預計這將促進 CSO 活動並支持行業市場。

這項研究的目的是揭示近年來各個細分市場和國家/地區的市場規模，並預測未來幾年的市場規模。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。

它還提供了關鍵方面的詳細信息，例如決定市場未來增長的驅動因素和挑戰。 此外，它還包含供利益相關者投資的潛在微觀市場機會，以及對主要參與者的競爭格局和產品的深入分析。 .

內容

第 1 章執行摘要

  • 市場概況
  • 2019-2029 年各細分市場的全球市場估計和預測
    • 2019-2029 年按地區分列的醫藥合同銷售代理市場
    • 按服務劃分的醫藥合同銷售代理市場，2019 年至 2029 年
    • 2019-2029 年按最終用途劃分的醫藥合同銷售代理市場
  • 主要趨勢
  • 調查方法
  • 調查先決條件

第 2 章全球合同營銷代理市場的定義和範圍

  • 調查目的
  • 市場定義和範圍
    • 調查範圍
    • 工業發展
  • 本次調查涵蓋的年份
  • 貨幣兌換率

第3章全球合同營銷組織的市場動態

  • 合同銷售代理市場影響分析（2019-2029）
    • 市場驅動力
      • 重振醫藥研發活動
      • 不斷發展的藥物開發
    • 市場挑戰
      • 醫藥寄售組織的高成本結構
    • 市場機會
      • 政府的高度承諾
      • 老年人口增加

第 4 章全球合同營銷代理市場行業分析

  • 波特 5 力模型
    • 供應商的議價能力
    • 買家的議價能力
    • 新進入者的威脅
    • 替代品的威脅
    • 競爭公司之間的敵對關係
  • 波特 5 力模型的未來方法 (2019-2029)
  • 害蟲分析
    • 政治
    • 經濟的
    • 社交
    • 技術
  • 投資招聘模式
  • 分析師的建議和結論
  • 主要投資機會
  • 關鍵成功策略

第 5 章風險評估：COVID-19 的影響

  • 評估 COVID-19 對行業的總體影響
  • COVID-19 之前和 COVID-19 之後的市場情景

第 6 章全球合同營銷代理市場：按服務分類

  • 市場概況
  • 全球合同銷售代理市場：按服務、按績效、潛力分析
  • 2019-2029 年按服務劃分的全球合同銷售代理市場估計和預測
  • 醫藥合同銷售代理市場，按細分市場分析
    • 個人宣傳
    • 非個人宣傳

第 7 章全球合同營銷代理市場：按最終用途分類

  • 市場概況
  • 全球合同銷售代理市場：按最終用途、性能潛力分析
  • 2019-2029 年全球合同銷售代理市場的最終用途估計和預測
  • 醫藥合同銷售代理市場，按細分市場分析
    • 製藥公司
    • 生物製藥公司

第 8 章全球合同營銷代理市場：區域分析

  • 醫藥合同銷售代理市場，按地區劃分的市場概況
  • 北美
    • 美國
      • 2019-2029 年各服務的估計和預測
      • 2019-2029 年按最終用途估算和預測
    • 加拿大
  • 歐洲合同營銷代理市場概況
    • 英國
    • 德國
    • 法國
    • 西班牙
    • 意大利
    • 其他歐洲
  • 亞太地區合同營銷代理市場概況
    • 中國
    • 印度
    • 日本
    • 澳大利亞
    • 韓國
    • 其他亞太地區
  • 拉丁美洲合同營銷代理市場概況
    • 巴西
    • 墨西哥
  • 世界其他地方

第 9 章衝突信息

  • 頂級市場策略
  • 公司簡介
    • 中民國際控股有限公司
      • 關鍵信息
      • 概覽
      • 財務（僅當數據可用時）
      • 產品概覽
      • 近期趨勢
    • Axxelus
    • EPS Corp.
    • QFR Solutions
    • MaBico
    • Mednext Pharma Pvt. Ltd.
    • Peak Pharma Solutions Inc.
    • IQVIA, Inc.
    • Promoveo Health
    • Syneous Health

第 10 章研究過程

  • 研究過程
    • 數據挖掘
    • 分析
    • 市場評估
    • 驗證
    • 出版
  • 調查的特點
  • 調查先決條件

Global Pharmaceutical Contract Sales Organizations Market is valued at approximately USD 7.90 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.4% over the forecast period 2022-2029. In order to expand the production capacity for vaccinations and other efficient treatment alternatives, the pharmaceutical sector has come under scrutiny. These advances are being used by market participants in the pharmaceutical contract sales outsourcing (CSO) sector to meet consumer and healthcare facility demand. Another significant factor generating income prospects for industry participants in the pharmaceutical contract sales outsourcing (CSO) sector is the increased knowledge of the immune system's potential. A rising desire for lower in-house sales costs, a rise in pharmaceutical R&D activities, and a rising number of new medication launches are a few of the major drivers of the industry's expansion. Moreover, high government initiatives and rising geriatric population are creating a lucrative growth opportunity for the market over the forecast period 2022-2029.

Companies that make biopharmaceuticals are currently concentrating on enhancing their research capacities. Almost 45% of all drugs in development in 2022, as per the Pharma R&D annual review, were biopharmaceuticals. It is anticipated that biopharmaceutical companies will outsource their sales activities to CSOs so they may concentrate on their research capabilities due to the great interest these companies have in research. However, the high cost of Pharmaceutical Contract Sales Organizations stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Pharmaceutical Contract Sales Organizations Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2022, North America had the largest market share, accounting for approximately 34.45% of global industry revenue. One of the main factors promoting the region's growth is the existence of a sizable number of CSOs there, including IQVIA, Inc., EPS Corp., and Axxelus. The demand for pharmaceutical CSOs is further supported by the region's embrace of new technology for pharmaceutical sales and a sizable number of new drug launches in the area. During the projected period, the Asia Pacific region is anticipated to increase at the fastest rate. The demand for CSO operations in the region is rising as a result of the substantial number of pharmaceutical and biopharmaceutical businesses in the area that are consistently developing novel treatments. In comparison to other developed areas, the region offers CSO services at a lower cost; this is anticipated to improve CSO activities and assist the sector market.

Major market players included in this report are:

  • CMIC Holdings Co., Ltd.
  • Axxelus
  • EPS Corp.
  • QFR Solutions
  • MaBico
  • Mednext Pharma Pvt. Ltd.
  • Peak Pharma Solutions Inc.
  • IQVIA, Inc.
  • Promoveo Health
  • Syneous Health

Recent Developments in the Market:

  • Dr Reddy's Laboratories and IQVIA, Inc. entered a partnership in September 2022. In accordance with the agreement, IQVIA gave Dr Reddy access to its Orchestrated Customer Engagement (OCE) platform to support its CRM activities. According to the deal, Dr Reddy gave IQVIA's OCE application to all of its marketing users and field staff in India so they could more effectively engage customers by integrating marketing, account management, medical scientific liaison, sales, and other activities.

Global Pharmaceutical Contract Sales Organizations Market Report Scope:

  • Historical Data: 2019-2020-2021
  • Base Year for Estimation: 2021
  • Forecast period: 2022-2029
  • Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered: Service, End-use, Region
  • Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Service offerings of key players. The detailed segments and sub-segment of the market are explained below.

By Service:

  • Personal Promotion
  • Non-personal Promotion

By End-use:

  • Pharmaceutical Companies
  • Biopharmaceutical Companies

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Pharmaceutical Contract Sales Organizations Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Pharmaceutical Contract Sales Organizations Market, by Service, 2019-2029 (USD Billion)
    • 1.2.3. Pharmaceutical Contract Sales Organizations Market, by End-use, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Pharmaceutical Contract Sales Organizations Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Pharmaceutical Contract Sales Organizations Market Dynamics

  • 3.1. Pharmaceutical Contract Sales Organizations Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. Increasing pharmaceutical R&D activities
      • 3.1.1.2. Growing drug development
    • 3.1.2. Market Challenges
      • 3.1.2.1. High Cost of Pharmaceutical Contract Sales Organizations
    • 3.1.3. Market Opportunities
      • 3.1.3.1. High government initiatives
      • 3.1.3.2. Rising geriatric population

Chapter 4. Global Pharmaceutical Contract Sales Organizations Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Pharmaceutical Contract Sales Organizations Market, by Service

  • 6.1. Market Snapshot
  • 6.2. Global Pharmaceutical Contract Sales Organizations Market by Service, Performance - Potential Analysis
  • 6.3. Global Pharmaceutical Contract Sales Organizations Market Estimates & Forecasts by Service 2019-2029 (USD Billion)
  • 6.4. Pharmaceutical Contract Sales Organizations Market, Sub Segment Analysis
    • 6.4.1. Personal Promotion
    • 6.4.2. Non-personal Promotion

Chapter 7. Global Pharmaceutical Contract Sales Organizations Market, by End-use

  • 7.1. Market Snapshot
  • 7.2. Global Pharmaceutical Contract Sales Organizations Market by End-use, Performance - Potential Analysis
  • 7.3. Global Pharmaceutical Contract Sales Organizations Market Estimates & Forecasts by End-use 2019-2029 (USD Billion)
  • 7.4. Pharmaceutical Contract Sales Organizations Market, Sub Segment Analysis
    • 7.4.1. Pharmaceutical Companies
    • 7.4.2. Biopharmaceutical Companies

Chapter 8. Global Pharmaceutical Contract Sales Organizations Market, Regional Analysis

  • 8.1. Pharmaceutical Contract Sales Organizations Market, Regional Market Snapshot
  • 8.2. North America Pharmaceutical Contract Sales Organizations Market
    • 8.2.1. U.S. Pharmaceutical Contract Sales Organizations Market
      • 8.2.1.1. Service breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. End-use breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Pharmaceutical Contract Sales Organizations Market
  • 8.3. Europe Pharmaceutical Contract Sales Organizations Market Snapshot
    • 8.3.1. U.K. Pharmaceutical Contract Sales Organizations Market
    • 8.3.2. Germany Pharmaceutical Contract Sales Organizations Market
    • 8.3.3. France Pharmaceutical Contract Sales Organizations Market
    • 8.3.4. Spain Pharmaceutical Contract Sales Organizations Market
    • 8.3.5. Italy Pharmaceutical Contract Sales Organizations Market
    • 8.3.6. Rest of Europe Pharmaceutical Contract Sales Organizations Market
  • 8.4. Asia-Pacific Pharmaceutical Contract Sales Organizations Market Snapshot
    • 8.4.1. China Pharmaceutical Contract Sales Organizations Market
    • 8.4.2. India Pharmaceutical Contract Sales Organizations Market
    • 8.4.3. Japan Pharmaceutical Contract Sales Organizations Market
    • 8.4.4. Australia Pharmaceutical Contract Sales Organizations Market
    • 8.4.5. South Korea Pharmaceutical Contract Sales Organizations Market
    • 8.4.6. Rest of Asia Pacific Pharmaceutical Contract Sales Organizations Market
  • 8.5. Latin America Pharmaceutical Contract Sales Organizations Market Snapshot
    • 8.5.1. Brazil Pharmaceutical Contract Sales Organizations Market
    • 8.5.2. Mexico Pharmaceutical Contract Sales Organizations Market
  • 8.6. Rest of The World Pharmaceutical Contract Sales Organizations Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. CMIC Holdings Co., Ltd.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Axxelus
    • 9.2.3. EPS Corp.
    • 9.2.4. QFR Solutions
    • 9.2.5. MaBico
    • 9.2.6. Mednext Pharma Pvt. Ltd.
    • 9.2.7. Peak Pharma Solutions Inc.
    • 9.2.8. IQVIA, Inc.
    • 9.2.9. Promoveo Health
    • 9.2.10. Syneous Health

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption

LIST OF TABLES

  • TABLE 1. Global Pharmaceutical Contract Sales Organizations Market, report scope
  • TABLE 2. Global Pharmaceutical Contract Sales Organizations Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Pharmaceutical Contract Sales Organizations Market estimates & forecasts by Service 2019-2029 (USD Billion)
  • TABLE 4. Global Pharmaceutical Contract Sales Organizations Market estimates & forecasts by End-use 2019-2029 (USD Billion)
  • TABLE 5. Global Pharmaceutical Contract Sales Organizations Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Pharmaceutical Contract Sales Organizations Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Pharmaceutical Contract Sales Organizations Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Pharmaceutical Contract Sales Organizations Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Pharmaceutical Contract Sales Organizations Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Pharmaceutical Contract Sales Organizations Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Pharmaceutical Contract Sales Organizations Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Pharmaceutical Contract Sales Organizations Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Pharmaceutical Contract Sales Organizations Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Pharmaceutical Contract Sales Organizations Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Pharmaceutical Contract Sales Organizations Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Pharmaceutical Contract Sales Organizations Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Pharmaceutical Contract Sales Organizations Market
  • TABLE 70. List of primary sources, used in the study of global Pharmaceutical Contract Sales Organizations Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Pharmaceutical Contract Sales Organizations Market, research methodology
  • FIG 2. Global Pharmaceutical Contract Sales Organizations Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Pharmaceutical Contract Sales Organizations Market, key trends 2021
  • FIG 5. Global Pharmaceutical Contract Sales Organizations Market, growth prospects 2022-2029
  • FIG 6. Global Pharmaceutical Contract Sales Organizations Market, porters 5 force model
  • FIG 7. Global Pharmaceutical Contract Sales Organizations Market, pest analysis
  • FIG 8. Global Pharmaceutical Contract Sales Organizations Market, value chain analysis
  • FIG 9. Global Pharmaceutical Contract Sales Organizations Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Pharmaceutical Contract Sales Organizations Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Pharmaceutical Contract Sales Organizations Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Pharmaceutical Contract Sales Organizations Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Pharmaceutical Contract Sales Organizations Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Pharmaceutical Contract Sales Organizations Market, regional snapshot 2019 & 2029
  • FIG 15. North America Pharmaceutical Contract Sales Organizations Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Pharmaceutical Contract Sales Organizations Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Pharmaceutical Contract Sales Organizations Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Pharmaceutical Contract Sales Organizations Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Pharmaceutical Contract Sales Organizations Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable